Exogenously administered d-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed mice

European Neuropsychopharmacology

Volumn 17, Issue 1, 2007, Pages 53-57

  Long, Katrice D ^a   Mastropaolo, John ^a   Rosse, Richard B ^a,b   Deutsch, Stephen I ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

d Serine; MK 801 (dizocilpine); NMDA receptor complex; Schizophrenia; Seizures

Indexed keywords

DIZOCILPINE; GLYCINE; MILACEMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG TREATMENT FAILURE; ELECTRIC POTENTIAL; ELECTRIC SHOCK; HINDLIMB; HYDROPHOBICITY; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEIZURE;

ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTROSHOCK; MALE; MICE; NEUROPROTECTIVE AGENTS; SEIZURES; SERINE;

EID: 33750980377     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.02.007     Document Type: Article

References (16)

1. Ascher P., and Johnson J.W. The NMDA receptor, its channel, and its modulation by glycine. In: Collingridge G.L., and Watkins J.C. (Eds). The NMDA Receptor. Second edition (1994), Oxford University Press, Oxford 177-205
2. Deutsch, S.I. et al., in press. Animal models of psychosis. In: Fisch, G.S., Flint, J. (Eds.), Transgenic and Knock out Models of Neuropsychiatric Disorders. Humana Press, Humana, Totowa, NJ.
3. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., and Morihisa J.M. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 12 1 (1989) 1-13
4. Deutsch S.I., Rosse R.B., and Mastropaolo J. Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice. Clin. Neuropharmacol. 20 5 (1997) 375-384
5. Deutsch S.I., Rosse R.B., Schwartz B.L., Powell D.G., and Mastropaolo J. Stress and a glycinergic intervention interact in the modulation of MK-801-elicited mouse popping behavior. Pharmacol. Biochem. Behav. 62 2 (1999) 395-398
6. Dunlop D.S., and Neidle A. The origin and turnover of d-serine in brain. Biochem. Biophys. Res. Commun. 235 (1997) 26-30
7. Horiike K., Tojo H., Arai R., Nozaki M., and Maeda T. d-Amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994) 297-303
8. Javitt D., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
9. Lane H.Y., Chang Y.C., Liu Y.C., Chiu C.C., and Tsai G.E. Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. Arch. Gen. Psychiatry 62 11 (2005) 1196-1204
10. +-independent transporter for small neutral amino acids that transports d-serine with high affinity. Neurosci. Lett. 287 (2000) 231-235
11. Norris D.O., Mastropaolo J., O'Connor D.A., Novitzki M., and Deutsch S.I. Glycinergic interventions potentiate the ability of MK-801 to raise the threshold voltage for tonic hindlimb extension in mice. Pharmacol. Biochem. Behav. 43 (1992) 609-612
12. Norris D.O., Mastropaolo J., O'Connor D.A., Cohen J.M., and Deutsch S.I. A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine. Neurochem. Res. 19 (1994) 161-165
13. Schell M.J., Molliver M.E., and Snyder S.H. d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
14. Schell M.J., Brady R.O., Molliver M.E., and Snyder S.H. d-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci. 17 (1997) 1604-1615
15. Tsai G., Yang P., Chung L., Lange N., and Coyle J.T. d-Serine added to antipsychotic for the treatment of schizophrenia. Biol. Psychiatry 44 (1998) 1081-1089
16. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414